Epilepsy is one of the leading neurological causes of death and disability worldwide, and Nepal is no exception. It significantly affects patients’ quality of life, productivity, and social well-being. In Nepal, epilepsy commonly results from conditions such as neurocysticercosis, congenital brain abnormalities, brain tumors, infections, and traumatic brain injuries. Although epilepsy can affect individuals of any age, it is most frequently observed in the 20–40 years age group in Nepal, which represents the most productive and socially active period of life.
Seizure attacks can be life-threatening, especially when they occur in unsafe environments such as swimming pools, high altitudes, or near open fire. Additionally, unrecognized or uncontrolled seizures are an important contributing factor to unexplained motor vehicle accidents in Nepal. Despite the availability of effective treatments, a large proportion of individuals with epilepsy in Nepal remain untreated due to lack of awareness, social stigma, and limited access to specialized healthcare services.
Studies show that nearly 30% of epilepsy patients continue to experience seizures despite being on anti-epileptic medications. Clinical evidence suggests that when seizures are not controlled with two appropriately chosen and tolerated anti-epileptic drugs, the likelihood of achieving seizure control by simply adding a third or fourth medication becomes very low. Furthermore, most patients require long-term or lifelong medication, which can lead to financial burden, side effects, and poor compliance.
Fortunately, advancements in neurodiagnostic technologies have significantly improved the ability to identify epileptogenic zones—the specific areas of the brain responsible for generating seizures. Targeting these areas through surgical and neuromodulation procedures has shown excellent outcomes in seizure control and overall patient quality of life.
Several surgical treatment options are now available for drug-resistant epilepsy, including lesionectomy, subpial resection, corpus callosotomy, and amygdalohippocampectomy. These procedures have been proven safe and effective in selected patients and can either eliminate seizures or significantly reduce their frequency and severity.
In recent years, Nepal has also witnessed the introduction of advanced neuromodulation techniques such as Vagal Nerve Stimulation (VNS) and Deep Brain Stimulation (DBS). These minimally invasive procedures are particularly beneficial for patients who are not suitable candidates for conventional epilepsy surgery. They have shown promising results in reducing seizure frequency and improving quality of life.
Increasing awareness among healthcare workers and the general public about drug-resistant epilepsy and its modern treatment options is crucial. Early referral to specialized epilepsy centers can help identify suitable candidates for advanced treatment and significantly reduce the burden of uncontrolled epilepsy in Nepal.
Drug-resistant epilepsy is no longer a condition without hope. With evolving diagnostic tools, surgical expertise, and neuromodulation therapies, Nepal is gradually moving towards comprehensive epilepsy care, offering new possibilities for seizure control and improved patient outcomes.